Valbiotis
ALVAL | PA
Overview
Corporate Details
- ISIN(s):
- FR0013254851
- LEI:
- 969500VP4JBJCF0MOP60
- Country:
- France
- Address:
- RUE PAUL VATINE, 17180 PERIGNY
- Website:
- https://www.valbiotis.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Valbiotis is a Research & Development company dedicated to scientific innovation for preventing and combating metabolic and cardiovascular diseases. To achieve this goal, Valbiotis has developed an exclusive and unique scientific approach founded on specific combinations of plant-based molecules. The active substances, which are called “Totum”, act directly on the key metabolic parameters of the body. Our unique approach focuses on prevention by providing health nutrition solutions.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-06 08:00 |
Capital/Financing Update
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintai…
|
English | 305.6 KB | |
| 2025-06-02 22:48 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 18.1 KB | |
| 2025-05-22 17:40 |
Regulatory News Service
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO® Cardio-circulation on 2 June
|
English | 235.0 KB | |
| 2025-05-22 17:40 |
Regulatory News Service
VALBIOTIS SA: Valbiotis commercialisera le 2 juin prochain sa solution Valbio…
|
French | 201.0 KB | |
| 2025-05-22 17:40 |
Regulatory News Service
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO Cardio-circulation on 2 June
|
English | 27.2 KB | |
| 2025-05-14 17:08 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 131.7 KB | |
| 2025-05-14 17:08 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 17.6 KB | |
| 2025-05-06 17:40 |
Earnings Release
VALBIOTIS SA: Strong Start to the Year in Line with the Company Roadmap: Expan…
|
English | 350.0 KB | |
| 2025-05-06 17:40 |
Earnings Release
VALBIOTIS SA: Extension du maillage commercial, lancements de produits, montée …
|
French | 238.8 KB | |
| 2025-05-06 17:40 |
Regulatory News Service
VALBIOTIS SA: Strong Start to the Year in Line with the Company Roadmap: Expan…
|
English | 40.8 KB | |
| 2025-04-18 17:54 |
Inside Information Statement
VALBIOTIS SA: Compte-rendu de l’Assemblée générale mixte du 18 avril 2025
|
French | 696.6 KB | |
| 2025-04-18 17:54 |
Regulatory News Service
VALBIOTIS SA: Compte-rendu de lAssemblee generale mixte du 18 avril 2025
|
French | 20.1 KB | |
| 2025-04-07 15:00 |
Regulatory News Service
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 17.3 KB | |
| 2025-03-31 17:40 |
General Meeting Notice
VALBIOTIS SA: Valbiotis annonce la tenue de son Assemblée générale mixte des ac…
|
French | 111.5 KB | |
| 2025-03-31 17:40 |
Regulatory News Service
VALBIOTIS SA: Valbiotis® strengthens its foothold in pharmacies with two strate…
|
English | 227.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-17 | N/A | Other | Other | 10,400 | 46,072.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Herantis Pharma Oyj | Finland | HRTIS | |
| Hiron-Trade Investments & Industrial Buildings Ltd. | Israel | HRON | ||
|
Human Stem Cells Institute PJSC | Russian Federation | ISKJ | |
|
Human Xtensions Ltd. | Israel | HUMX | |
|
Hybrigenics SA | France | ALHYG | |
|
Hyloris Pharmaceuticals SA | Belgium | HYL | |
|
Ikonisys S.A. | France | ALIKO | |
|
IMCB PJSC | Russian Federation | GEMA | |
|
Inify Laboratories AB | Sweden | INIFY | |
|
Innate Pharma | France | IPH |